A systematic review of therapeutic facet joint interventions in chronic spinal pain.
Mark V Boswell, James D Colson, Nalini Sehgal...
https://pubmed.ncbi.nlm.nih.gov/17256032/Actively Recruiting
Led by R3 Stem Cell · Updated on 2024-04-11
100
Participants Needed
4
Research Sites
52 weeks
Total Duration
Researchers are evaluating the safety and feasibility of using umbilical cord Whartons Jelly WJ allograft injections for people suffering from chronic low back pain. This pilot study is open label and non-controlled, involving 100 participants. It aims primarily to assess safety while also monitoring pain relief and functional improvements over one year. Participants will receive a series of lumbar injections containing 10cc of WJ allograft. There is no control group, and the study is designed as a phase 1 trial. The treatment involves minimal manipulation of umbilical cord tissue delivered directly to the lumbar area as described in the protocol. Throughout the study, participants will undergo baseline assessments including outcome questionnaires, imaging, and laboratory tests. Safety and efficacy will be monitored through blood tests for inflammation and organ function at baseline and multiple follow-up points up to one year. Pain and function will also be tracked using various surveys and scales at scheduled intervals. The total study duration for each participant is one year.
CONDITIONS
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
D
David L Greene, MD, PhD, MBA
K
Katherine Minter-Dykhouse, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
R3 Stem Cell
Lead Sponsor
R3 Medical Research
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Wharton's Jelly Allograft Injection | Epidural Steroid Injection (Current Practice) |
|---|---|---|
| What it is | A single lumbar injection of minimally manipulated umbilical cord Wharton's Jelly allograft, intended to explore safety and feasibility for adults with chronic low back pain. | Injection of corticosteroid medication into the lumbar epidural space, commonly performed to manage chronic lumbar pain not responsive to conservative measures. |
| Role in the study | Investigational intervention assessed for safety and feasibility in a single-arm, prospective study. | Represents a widely used interventional procedure for chronic lumbar pain in current standard clinical practice. |
| Primary use | Being evaluated for potential to relieve pain and improve function in adults with moderate to severe chronic lumbar pain. | Used to reduce lumbar pain and inflammation and facilitate functional improvement when conservative treatments have failed. |
| How it is given or performed | A single 10cc injection of Wharton's Jelly allograft is administered into the lumbar region under imaging guidance in an outpatient setting. | Epidural space injection of corticosteroid, typically guided by fluoroscopy or ultrasound, often given as a series of one or more outpatient procedures. |
| Evidence status | Early-stage clinical evidence; no outcome data available yet on safety, efficacy, or durability for lumbar pain. Larger studies needed to establish benefit. | Supported by multiple randomized trials and systematic reviews as offering short- to intermediate-term pain reduction in some patients with chronic lumbar pain, though long-term benefit may be limited. |
| Important limitations | Long-term safety and effectiveness in lumbar pain are unknown; trial does not compare directly to other interventions; risks and benefits are not yet established. | Variable benefit; may require repeated injections; potential for limited duration of relief, and not all patients respond. Risks of infection, bleeding, and rare but severe neurological complications exist. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment session
Participants receive a series of lumbar injections with 10cc of Umbilical Cord Wharton's Jelly Allograft.
1 treatment visit (in-person)
Duration - 1 year
Participants are followed for one year for evaluation of safety, pain relief, and functional improvements with regular assessments.
Visits at 24 hours, 1 week, 6 weeks, 3 months, 6 months, and 1 year after treatment
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Mark V Boswell, James D Colson, Nalini Sehgal...
https://pubmed.ncbi.nlm.nih.gov/17256032/Peter Fritzell, Olle Hägg, Anders Nordwall...
https://pubmed.ncbi.nlm.nih.gov/12709856/J N Alastair Gibson, Gordon Waddell
https://pubmed.ncbi.nlm.nih.gov/16227895/Ashim Gupta, Nicola Maffulli
https://pubmed.ncbi.nlm.nih.gov/35921598/E N Hanley, S M David
https://pubmed.ncbi.nlm.nih.gov/10360702/J N Gibson, I C Grant, G Waddell
https://pubmed.ncbi.nlm.nih.gov/10488513/R A Deyo, J N Weinstein
https://pubmed.ncbi.nlm.nih.gov/11172169/Gala M Godoy-Brewer, Oluwafemi P Owodunni, Alyssa M Parian...
https://pubmed.ncbi.nlm.nih.gov/35001050/R3 Stem Cell
Lead Sponsor
R3 Medical Research
Collaborating Sponsor